Bullboard - Stock Discussion Forum Forte Biosciences Inc FBRX

Healthcare Biotechnology

Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases. The Company is advancing its product candidate, FB-102, which is a proprietary molecule with potentially broad autoimmune applications, including in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). The Company’s FB-102 program... see more

Add To Watchlist

NDAQ:FBRX - Post Discussion

Forte Biosciences Inc > Forte Biosciences: Biotech with Explosive Potential

View:

Post by AlphaSurge34 on Nov 29, 2024 8:43am

Forte Biosciences: Biotech with Explosive Potential

Forte’s trial results are turning heads, and institutional investors are starting to take notice. With the right backing, a 2–3x move from here isn’t just possible—it’s likely. The biotech sector thrives on innovation, and MYNZ, while in diagnostics, continues to show how innovation drives opportunity.